AGILENT TECHNOLOGIES Reports Third Quarter Earnings for FY2023

August 27, 2023

🌥️Earnings Overview

For the third quarter of FY2023, AGILENT TECHNOLOGIES ($NYSE:A) reported total revenue of USD 1672.0 million, a decline of 2.7% compared to the same quarter of the previous year. Net income for this period was USD 111.0 million, representing a decrease of 66.3% year-on-year.

Market Price

The stock opened at $126.3 and closed at $125.6, resulting in a 0.8% decrease from the last closing price of 126.6. This demonstrates the company’s resilience and strength in the face of market uncertainty. Looking ahead, AGILENT TECHNOLOGIES is confident in their ability to continue providing innovative products and services in the coming quarters, and they remain optimistic about their future prospects. Investors should continue to keep an eye on AGILENT TECHNOLOGIES as they remain one of the top performers in the industry. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Agilent Technologies. More…

    Total Revenues Net Income Net Margin
    6.99k 1.13k 16.2%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Agilent Technologies. More…

    Operations Investing Financing
    1.7k -380 -1.07k
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Agilent Technologies. More…

    Total Assets Total Liabilities Book Value Per Share
    10.68k 5.12k 18.97
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Agilent Technologies are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    10.2% 21.0% 21.0%
    FCF Margin ROE ROA
    20.3% 16.2% 8.6%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    At GoodWhale, we recently conducted an in-depth analysis of AGILENT TECHNOLOGIES‘ fundamentals to provide investors with an understanding of how it stands. Our findings show that AGILENT TECHNOLOGIES is a medium risk investment when it comes to financial and business aspects. We have also detected two risk warnings in the balance sheet and non-financial areas. If you’re interested in learning more about these potential risks, we invite you to register with us and see the results of our analysis for yourself. With our comprehensive overview of AGILENT TECHNOLOGIES’s fundamentals, you can make informed decisions about investing in the company. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis

  • Peers

    The company has a strong presence in the market and competes with Qiagen NV, Thermo Fisher Scientific Inc, Illumina Inc, and other companies. Agilent Technologies Inc. is committed to providing innovative products and services that meet the needs of customers and enable them to achieve their research goals.

    – Qiagen NV ($NYSE:QGEN)

    Qiagen is a Dutch company that provides molecular diagnostic solutions, including kits and instruments for sample preparation and real-time PCR. The company has a market cap of 9.99B as of 2022 and a ROE of 13.07%.

    – Thermo Fisher Scientific Inc ($NYSE:TMO)

    Thermo Fisher Scientific Inc is a biotechnology company that manufactures and sells scientific instruments, reagents, and laboratory products. The company has a market capitalization of 201.37 billion as of 2022 and a return on equity of 12.43%. Thermo Fisher Scientific is a global leader in serving science, with revenues of more than $30 billion and a workforce of more than 70,000 employees. The company’s mission is to enable its customers to make the world healthier, cleaner, and safer.

    – Illumina Inc ($NASDAQ:ILMN)

    Illumina Inc. is an American company headquartered in San Diego, California. It is a provider of sequencing and array-based solutions for genetic analysis. The company has a market cap of $36.65 billion as of 2022 and a return on equity of 0.28%. Illumina’s products are used by academic and commercial researchers in a variety of fields, including cancer, infectious disease, genetics, and more.


    Investors considering AGILENT TECHNOLOGIES should be aware of the company’s latest financial results for the third quarter of FY2023, ending July 31 2023. Total revenue was USD 1672.0 million, a decrease of 2.7% year-on-year, while net income decreased by 66.3% to USD 111.0 million. Analysts predict the company’s earnings to increase in the coming quarters, due to its focus on cost containment and innovation. Investors may want to consider whether AGILENT TECHNOLOGIES’ current share price presents good value for money.

    Recent Posts

    Leave a Comment